Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC3153
TNBC
Basal A
Cisplatin
DNA cross-linker
DNA cross-linker
10056.021
uM
8.47820
15.30870
-0.9575 -0.9929 1.8511 0.4902
0.9885
0.8839
HCC3153
TNBC
Basal A
CGC-11047
Polyamine analogue
10056.034
uM
4.94730
53.82750
-0.9867 -1.0000 0.4603 0.7287
0.9511
0.8648
HCC3153
TNBC
Basal A
CPT-11
TOP1
TOP
10056.034
uM
17.11390
33.29250
-0.5855 -1.0000 1.6509 0.1346
0.9910
0.8648
HCC3153
TNBC
Basal A
Doxorubicin
TOP2
TOP
10056.034
uM
0.47320
0.88785
-0.9212 -0.8902 1.6250 0.6566
0.9982
0.8648
MCF12A
NM
Basal B
GSK923295
CENPE
Kinesin
10061.001
uM
2.01520
9.19330
-0.7674 -1.0000 0.7238 0.3226
0.8034
1.7406
MCF12A
NM
Basal B
GSK1070916
AURK
AURK
10061.001
uM
7.05180
18.47620
-0.3544 -1.0000 1.1406 0.2085
0.9378
1.7406
MCF12A
NM
Basal B
GSK461364
PLK1
PLK
10061.001
uM
1.47950
7.65830
-0.8558 -1.0000 0.6682 0.3189
0.8112
1.7406
MCF12A
NM
Basal B
Docetaxel
TUBB
TUBB
10061.002
uM
0.03596
0.00551
0.4666 0.4502 1.2301 0.3153
0.9765
1.8759
MCF12A
NM
Basal B
Taxol
TUBB
TUBB
10061.002
uM
0.02796
0.01249
0.1491 0.3357 1.3814 0.3870
0.9179
1.8759
MCF12A
NM
Basal B
17-AAG
HSP90
HSP90
10061.037
uM
0.03509
0.03844
-0.6495 -0.2882 5.0000 0.8377
0.6366
1.7478
MCF12A
NM
Basal B
Gefitinib
EGFR
ErbB
10061.049
uM
0.87261
3.62350
-0.8055 -1.0000 0.7717 0.3691
0.9583
1.7845
MCF12A
NM
Basal B
Geldanamycin
HSP90
HSP90
10061.049
uM
0.02306
0.03084
-0.5939 -0.5800 2.6507 0.9816
0.9988
1.7845
MCF12A
NM
Basal B
Cisplatin
DNA cross-linker
DNA cross-linker
10061.049
uM
inf
651.48010
0.8972 0.5117 4.9986 -0.0089
0.6029
1.7845
MCF12A
NM
Basal B
Gemcitabine
DNA replication
DNA replication
10061.12
uM
0.28867
0.25213
0.0671 0.0377 0.5785 0.4089
0.9672
2.0669
MCF12A
NM
Basal B
Carboplatin
DNA cross-linker
DNA cross-linker
10061.12
uM
180.30870
388.26890
-0.7598 -1.0000 1.4323 0.2270
0.9929
2.0669
MCF12A
NM
Basal B
Oxaliplatin
DNA cross-linker
DNA cross-linker
10061.12
uM
4.1260
26.98840
-0.7649 -1.0000 0.5850 0.5535
0.9255
2.0669
MCF12A
NM
Basal B
Doxorubicin
TOP2
TOP
10061.121
uM
0.14208
0.22393
-0.8447 -0.8402 2.1671 0.8756
0.9950
1.9364
MCF12A
NM
Basal B
CPT-11
TOP1
TOP
10061.121
uM
2.59920
8.08440
-0.2192 -0.4707 0.5847 0.2889
0.9746
1.9364
MCF12A
NM
Basal B
Topotecan
TOP1
TOP
10061.121
uM
0.07619
0.55398
-0.8083 -0.9793 0.5467 0.8270
0.9781
1.9364
MCF12A
NM
Basal B
Trastuzumab
HER2
ErbB
10061.123
uM
17.14380
8.78160
0.8599 0.4824 4.9997 -0.0107
0.7497
1.9064
MCF12A
NM
Basal B
CGC-11047
Polyamine analogue
10061.123
uM
inf
1.94010
0.5944 0.5842 0.7640 0.1252
0.9147
1.9064
MCF12A
NM
Basal B
Cetuximab
EGFR
ErbB
10061.123
uM
1.02740
2.52820
0.6599 -0.9860 1.2097 0.0245
0.9609
1.9064
MCF7
HR+
Luminal
GSK923295
CENPE
Kinesin
10073.001
uM
1.43130
16.74890
-0.3255 -1.0000 0.4466 0.3080
0.9058
0.5923
MCF7
HR+
Luminal
GSK461364
PLK1
PLK
10073.001
uM
0.60343
7.16960
-0.9451 -1.0000 0.4439 0.4232
0.5927
0.5923
MCF7
HR+
Luminal
GSK1070916
AURK
AURK
10073.001
uM
10.70090
17.87270
-0.5853 -1.0000 2.1418 0.2123
0.9462
0.5923